Status: Recruiting
Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis
The purpose of this study is to assess the safety, tolerability and pharmacokinetics single and multiple inhaled doses of CMR316 in healthy volunteers and patients with Idiopathic Pulmonary Fibrosis (IPF).
Participants needed: 106
Trial details
Phase: Phase 1Age: 18-60Biological sex: AllType: InterventionalSponsor: Calibr, a division of Scripps ResearchUpdated: Apr 23, 2025Locations: 1
Eligibility criteria
Healthy men or non-pregnant, non-lactating healthy women of non-childbearing pot... [+13]
Serious adverse reaction or serious hypersensitivity to any drug or the formulat... [+39]